Oral Appliance Therapy (OAT) for Obstructive Sleep Apnoea (OSA) on cardiovascular risk markers

Not Applicable

Recruiting

• Conditions: obstructive sleep apnoea; Respiratory - Sleep apnoea

• Registration Number: ACTRN12621000395831
• Lead Sponsor: orthern Sydney Local Health District

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-04-09
• Last Update Posted: 19 April 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 105

Inclusion Criteria

Obstructive Sleep Apnoea (with ODI(4%) > 10 events/hour)
BMI < 35 kgm2

Exclusion Criteria

Use of any OSA therapy in the prior 3 months
Contra-indications to OAT (as determined by dentist e.g. periodontal disease, insufficient number of teeth to retain the device)
Women who are lactating or pregnant
Established cardio- or cerebro-vascular disease (E.g. stroke, coronary heart disease, heart failure, cardiomyopathy, congenital heart disease)
Central Sleep Apnoea (>10% central events)
Co-existing sleep disorder of lung disease (e.g. COPD)
Inability to provide informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified